Fendong Pharmaceutical: Adjusts the upper limit of the stock repurchase price to 11.40 yuan/share.

Zhendong Pharmaceutical announced that, in order to ensure the smooth implementation of the share repurchase plan, the company will adjust the upper limit of the repurchase price from RMB 6.00 per share to RMB 11.40 per share. This price shall not exceed 150% of the average trading price of the company's stock in the 30 trading days prior to the resolution of the adjusted proposal by the board of directors. The adjusted upper limit of the repurchase price shall take effect from August 25, 2025. The total amount of the repurchase shall not be less than RMB 50 million and shall not exceed RMB 100 million.